Cynosure, Inc. Announces Key Marketing Approvals in Asia and South America

WESTFORD, Mass., May 17 /PRNewswire-FirstCall/ -- Cynosure, Inc., (Nasdaq: CYNO) today announced four international regulatory approvals that extend the reach of the company’s proprietary aesthetic laser systems in Asia and South America.

Elite MPX, Cynosure’s unique dual-wavelength platform for an array of aesthetic applications, was approved for marketing in Korea. Elite MPX and the Elite Aesthetic Workstation, which combines two wavelengths for safe and effective laser hair removal on virtually any skin type, were awarded marketing authorization in Colombia. Smartlipo MPX, one of the newest members of Cynosure’s award-winning family of LaserBodySculpting(SM) workstations, received approval in Hong Kong. The company maintains a direct sales office in Korea and distributor relationships in Colombia and Hong Kong.

Including the products covered by today’s announcement, four of Cynosure’s flagship products are marketed in Colombia, five are sold in Korea and eight in Hong Kong.

“Overseas markets represent an important growth engine for Cynosure, as reflected in the 70 percent increase we achieved in international laser revenue in the first quarter of this year,” said President and Chief Executive Officer Michael Davin. “Securing additional product approvals outside of North America is one of the strategic objectives we have established for 2010. With these clearances in Asia and South America the year is off to a strong start. We continue to build a successful sales and marketing presence overseas, and based on the reception to our products we are enthusiastic about the potential of our international business as we move ahead.”

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosures products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.

Forward-Looking Statements

Any statements in this news release about future expectations, plans and prospects for Cynosure, Inc., including statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the global economy and lending environment and their effects on the aesthetic laser industry, Cynosure’s history of operating losses, its reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, changes in consumer preferences, competition in the aesthetic laser industry, economic, market, technological and other factors discussed in Cynosure’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this news release represent Cynosure’s views as of the date of this news release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, while Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure’s views as of any date subsequent to the date of this news release.

SOURCE Cynosure, Inc.